Bacterial lysate increases the percentage of natural killer T cells in peripheral blood and alleviates asthma in children

Pharmacology

Volumn 95, Issue 3-4, 2015, Pages 139-144

  Lu, Yanming ^a   Li, Yaqin ^a   Xu, Lingyun ^a   Xia, Min ^a   Cao, Lanfang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Asthma; Bacterial lysate; Children; Natural killer T cells

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM LYSATE; CORTICOSTEROID; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; ALPHA-GALACTOSYLCERAMIDE; BRONCHO-VAXOM; CELL EXTRACT; GALACTOSYLCERAMIDE; IL10 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; IMMUNOLOGICAL ADJUVANT;

ADD ON THERAPY; ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; CD4 LYMPHOCYTE COUNT; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER T CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; LYMPHOCYTE COUNT; PRESCHOOL CHILD;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ASTHMA; CELL EXTRACTS; CHILD; CHILD, PRESCHOOL; FEMALE; GALACTOSYLCERAMIDES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; LYMPHOCYTE COUNT; MALE; NATURAL KILLER T-CELLS;

EID: 84926142680     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000377683     Document Type: Article

References (23)

1. Masoli M, Fabian D, Holt S, Beasley R: The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59: 469-478.
2. Message SD, Johnston SL: Viruses in asthma. Br Med Bull 2002; 61: 29-43.
3. Weinberger M: Can we prevent exacerbations of asthma caused by common cold viruses J Allergy Clin Immunol 2010; 126: 770-771.
4. Siwiec J, Zaborowski T, Jankowska O, Wojas-Krawczyk K, Krawczyk P, Milanowski J: Evaluation of Th1/Th2 lymphocyte balance and lipopolysaccharide receptor expression in asthma patients (in Polish). Pneumonol Alergol Pol 2009; 77: 123-130.
5. Velissariou IM, Papadopoulos NG: The role of respiratory viruses in the pathogenesis of pediatric asthma. Pediatr Ann 2006; 35: 637-642.
6. Callaway Z, Kim CK: Respiratory viruses, eosinophilia and their roles in childhood asthma. Int Arch Allergy Immunol 2011; 155: 1-11.
7. Hakim F, Vilozni D, Adler A, Livnat G, Tal A, Bentur L: The effect of montelukast on bronchial hyperreactivity in preschool children. Chest 2007; 131: 180-186.
8. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, et al: Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 2011; 127: 372-381.e1-e3.
9. Hollams EM, Hales BJ, Bachert C, Huvenne W, Parsons F, de Klerk NH, et al: Th2-associated immunity to bacteria in teenagers and susceptibility to asthma. Eur Respir J 2010; 36: 509-516.
10. McKean M, Ducharme F: Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database Syst Rev 2000; 2:CD001107.
11. Schaad UB: OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J Pediatr 2010; 6: 5-12.
12. Steurer-Stey C, Lagler L, Straub DA, Steurer J, Bachmann LM: Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review. Eur J Pediatr 2007; 166: 365-376.
13. Subspecialty Group of Respiratory Diseases Society of Pediatrics; Chinese Medical Association; Chinese Journal of Pediatrics Editorial Board: Guideline for the diagnosis and optimal management of asthma in children (in Chinese). Zhonghua Er Ke Za Zhi 2008; 46: 745-753.
14. De Benedetto F, Sevieri G: Prevention of respiratory tract infections with bacterial lysate OM-85 bronchomunal in children and adults: a state of the art. Multidiscip Respir Med 2013; 8: 33.
15. Ruah SB, Ruah C, van Aubel A, Abel S, Elsasser U: Efficacy of a polyvalent bacterial lysate in children with recurrent respiratory tract infections. Adv Ther 2001; 18: 151-162.
16. Jareoncharsri P, Bunnag C, Tunsuriyawong P, Assanasane P, Voraprayoon S, Pinkaew B: An open-label, prospective study of an oral polyvalent bacterial lysate (Luivac ® ) in the treatment of recurrent respiratory tract infections in Thai patients. Asian Pac J Allergy Immunol 2003; 21: 223-230.
17. Navarro S, Cossalter G, Chiavaroli C, Kanda A, Fleury S, Lazzari A, et al: The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways. Mucosal Immunol 2010; 4: 53-65.
18. Roy A, Chorostowska-Wynimko J: Bacterial immunostimulants-mechanism of action and clinical application in respiratory diseases. Pneumonol Alergol Pol 2008; 76: 353-359.
19. Huber M, Mossmann H, Bessler W: Th1-orientated immunological properties of the bacterial extract OM-85-BV. Eur J Med Res 2005; 10: 209-217.
20. Banche G, Allizond V, Mandras N, Garzaro M, Cavallo G, Baldi C, et al: Improvement of clinical response in allergic rhinitis patients treated with an oral immunostimulating bacterial lysate: in vivo immunological effects. Int J Immunopathol Pharmacol 2007; 20: 129-138.
21. Bendelac A, Savage PB, Teyton L: The biology of NKT cells. Annu Rev Immunol 2007; 25: 297-336.
22. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo J-L, Libby P, Weissleder R, Pittet MJ: The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007; 204: 3037-3047.
23. Yan-Ming L, Lan-Fang C, Chen L, Ya-Qin L, Wei C, Wen-Ming Z: The effect of specific immunotherapy on natural killer T cells in peripheral blood of house dust mite-sensitized children with asthma. Clin Dev Immunol 2012; 2012: 148262.